Since the start of the pandemic, the team at biotechnology company BioSellal has been applying its expertise in animal health diagnostics to help improve the detection of COVID-19 and its variants. In this video, Eric Sellal, CEO of BioSellal, shares insight into the company’s work developing and validating real-time PCR and ELISA methods for the reliable antibody detection.